Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
214,467,875
-
Total 13F shares
-
22,319,507
-
Share change
-
+592,618
-
Total reported value
-
$88,607,906
-
Put/Call ratio
-
49%
-
Price per share
-
$3.97
-
Number of holders
-
65
-
Value change
-
+$2,352,091
-
Number of buys
-
31
-
Number of sells
-
26
Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q1 2019
As of 31 Mar 2019,
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,319,507 shares.
The largest 10 holders included
SUMMER ROAD LLC, BlackRock Inc., Versant Venture Management, LLC, Opaleye Management Inc., FMR LLC, Man Group plc, VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, Endurant Capital Management LP, and SV Health Investors, LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.